Evolving Impact of COVID‐19 on Transplant Center Practices and Policies in the United States
Brian J. Boyarsky(Johns Hopkins University), Jacqueline Garonzik‐Wang(University of Wisconsin–Madison), Talia Baker(University of Utah), Christine M. Durand(University of Maryland, Baltimore), Teresa Po‐Yu Chiang(Johns Hopkins University), Allan B. Massie(Johns Hopkins University), Amber Kernodle(Brigham and Women's Hospital), Dorry L. Segev(New York University), Alexandra T. Strauss(Johns Hopkins University), Sarah E. Van Pilsum Rasmussen(Johns Hopkins University), Kyle R. Jackson(Johns Hopkins University), William A. Werbel(Johns Hopkins University), Jessica M. Ruck(Johns Hopkins University), Fawaz Al Ammary(Johns Hopkins University), Samantha Getsin(Johns Hopkins University), Robin K. Avery(Johns Hopkins University)
Cited by 36
Related Papers
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Foot strike patterns and collision forces in habitually barefoot versus shod runners
|Nature|2010|1.4k
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
|American Journal of Transplantation|2017|1k